Skip to main content
. 2006 May;22(7):606–613. doi: 10.1016/s0828-282x(06)70283-5

Figure 3.

Figure 3

Calibration of the Framingham model and the Cardiovascular Life Expectancy Model. Each model was used to estimate the risk of each Canadian subject in the Lipid Research Clinics Follow-Up Cohort, and all subjects were then rank-ordered from the lowest to highest risk. Dividing the cohort into risk quartiles, the mean risk estimated for each quartile was compared with the coronary death rate actually observed